» Articles » PMID: 16942746

Assay for the Quantification of Intact/fragmented Genomic DNA

Overview
Journal Anal Biochem
Publisher Elsevier
Specialty Biochemistry
Date 2006 Sep 1
PMID 16942746
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

This study shows that the accuracy of the quantification of genomic DNA by the commonly used Hoechst- and PicoGreen-based assays is drastically affected by its degree of fragmentation. Specifically, it was shown that these assays underestimate by 70% the concentration of double-stranded DNA (dsDNA) with sizes less than 23 kb. On the other hand, DNA sizes greater and less than approximately 23 kb are commonly characterized as intact and fragmented genomic DNA, respectively, by the agarose electrophoresis DNA smearing assay and are evaluated only qualitatively by this assay. The need for accurate quantification of fragmented and total genomic DNA, combined with the lack of specific, reliable, and simple quantitative methods, prompted us to develop a Hoechst/PicoGreen-based fluorescent assay that quantifies both types of DNA. This assay addresses these problems, and in its Hoechst and PicoGreen version it accurately quantifies dsDNA as being either intact (>or=23 kb) or fragmented (<23 kb) in concentrations as low as 3 ng ml-1 or 5 pg ml-1 with Hoechst or PicoGreen, respectively, as well as the individual fractions of intact/fragmented DNA existing in any proportions in a total DNA sample in concentrations as low as 10 ng ml-1 or 15 pg ml-1 with Hoechst or PicoGreen, respectively. Because the assay discriminates total genomic DNA in the two size ranges (>or=23 and <23 kb) and quantitates them, it is proposed as the quantitative replacement of the agarose gel electrophoresis genomic DNA smearing assay.

Citing Articles

Determination of DNA content as quality control in decellularized tissues: challenges and pitfalls.

Philips C, Terrie L, Muylle E, Thorrez L Regen Biomater. 2024; 11:rbae123.

PMID: 39569078 PMC: 11578598. DOI: 10.1093/rb/rbae123.


Comparison of DeNovix, NanoDrop and Qubit for DNA quantification and impurity detection of bacterial DNA extracts.

Versmessen N, Van Simaey L, Negash A, Vandekerckhove M, Hulpiau P, Vaneechoutte M PLoS One. 2024; 19(6):e0305650.

PMID: 38885212 PMC: 11182499. DOI: 10.1371/journal.pone.0305650.


Development of Sensitive Methods for the Detection of Minimum Concentrations of DNA on Martian Soil Simulants.

Li Y, Rochfort K, Collins D, Grintzalis K Life (Basel). 2023; 13(10).

PMID: 37895382 PMC: 10608431. DOI: 10.3390/life13101999.


Quantitative analysis of serum cell-free DNA as a predictive and prognostic marker in breast cancer patients.

Sultana G, Akter F, Israfil S, Ray U, Jahan R, Ali M Front Oncol. 2023; 13:1171412.

PMID: 37427131 PMC: 10324030. DOI: 10.3389/fonc.2023.1171412.


Modelling clinical DNA fragmentation in the development of universal PCR-based assays for bisulfite-converted, formalin-fixed and cell-free DNA sample analysis.

Johnston A, Lu J, Korbie D, Trau M Sci Rep. 2022; 12(1):16051.

PMID: 36163372 PMC: 9512909. DOI: 10.1038/s41598-022-18196-7.